Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Tribune France.
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
Press releases published on May 5, 2025

AgileOne Recognized as Top Global MSP Provider by HRO Today
AgileOne is honored to share that the company has been selected as the top global Managed Service Provider (MSP) by HRO Today. TORRANCE, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- AgileOne is honored to share that the company has been selected …

AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting
PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO PRESENTATIONS AT THE 2025 ENCALS ANNUAL MEETING MASITINIB REDUCES SERUM NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS, SUGGESTING THAT IT HAS …

AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTERA LORS DE LA RÉUNION ANNUELLE DE L'ENCALS EN 2025 DE NOUVELLES DONNÉES ISSUES DU PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LE MASITINIB RÉDUIT LA CONCENTRATION SERIQUE …

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified conditions. Daix (France), New York City (New York, United States), May 5, 2025 – Inventiva (Euronext Paris and Nasdaq: …

Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros
Le financement intervient à la suite de la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et à la suite de l’atteinte d’autres conditions préalables. Daix (France), New York City (New York …

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, 2025 – Roquette, a global leader in plant-based …

Roquette présente une nouvelle organisation à la suite de l’acquisition d’IFF Pharma Solutions
Roquette présente une nouvelle organisation à la suite de l’acquisition d’IFF Pharma Solutions L’entreprise se structure avec deux Business Groups repensés et renforcés, et nomme leurs nouveaux dirigeants Lille, le 5 mai 2025 – Roquette, un leader mondial …